Axe Compute

Axe Compute Inc., headquartered in Pittsburgh, Pennsylvania, is a publicly traded company on NASDAQ under the ticker symbol AGPU that provides dedicated, bare-metal enterprise GPU infrastructure for artificial intelligence workloads without hyperscaler lock-in, long waitlists, or surprise fees. Formerly known as Predictive Oncology Inc., the compan... y changed its name to Axe Compute Inc. in December 2025, reflecting its strategic expansion into high-performance enterprise AI infrastructure while continuing to operate its AI-driven drug discovery business. Founded in 2002, Axe Compute operates through two segments: Pittsburgh and Eagan. The Pittsburgh segment applies artificial intelligence using a proprietary biobank of over 150,000 tumor samples to support the discovery and development of cancer therapies, creating proprietary 3D culture models used in drug development and maintaining a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company's fundamental observation about the current AI landscape is that the bottleneck to AI progress is increasingly infrastructure rather than algorithms, with enterprises building AI applications facing immediate challenges in accessing the compute required to train and run models. Axe Compute plans to operate by utilizing the Aethir network to provide specific, dedicated GPU capacity that AI-native companies require when cloud queues are too long and building internal infrastructure is too slow, becoming the first publicly traded company with the intention to commercialize decentralized GPU infrastructure at enterprise scale. The company anticipates sourcing infrastructure at competitive rates and providing reliable, predictable access to high-capacity compute through the Aethir network, introducing the flexibility of a resource pool that can be allocated to ...Read More